Stock Scorecard



Stock Summary for Dynavax Technologies Corp (DVAX) - $11.34 as of 4/19/2024 3:50:17 PM EST

Total Score

6 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DVAX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DVAX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DVAX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for DVAX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for DVAX

Dynavax Technologies ( NASDAQ:DVAX ) Downgraded to "Hold" at StockNews.com 4/18/2024 9:56:00 AM
MannKind Announces CFO Transition - MannKind ( NASDAQ:MNKD ) 3/26/2024 8:05:00 PM
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate 3/26/2024 6:00:00 AM
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate 3/26/2024 6:00:00 AM
Dynavax Technologies ( NASDAQ:DVAX ) Upgraded to "Buy" at StockNews.com 3/7/2024 9:56:00 AM
Dynavax Technologies ( DVAX ) Q4 2023 Earnings Call Transcript 2/23/2024 1:00:00 AM
Dynavax Technologies ( DVAX ) Reports Break-Even Earnings for Q4 2/22/2024 10:15:00 PM
Stocks With Rising Relative Strength: Dynavax Technologies 1/17/2024 8:00:00 AM
Why Vera Therapeutics Stock Soared by 22% This Week 1/12/2024 11:44:00 PM
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer - Vera Therapeutics ( NASDAQ:VERA ) 1/8/2024 1:01:00 PM

Financial Details for DVAX

Company Overview

Ticker DVAX
Company Name Dynavax Technologies Corp
Country USA
Description Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 4/30/2024

Stock Price History

Last Day Price 11.34
Last Day Price Updated 4/19/2024 3:50:17 PM EST
Last Day Volume 0
Average Daily Volume 1,868,069
52-Week High 15.15
52-Week Low 10.06
Last Price to 52 Week Low 12.72%

Valuation Measures

Trailing PE N/A
Industry PE 100.90
Sector PE 61.34
5-Year Average PE -39.58
Free Cash Flow Ratio 2.00
Industry Free Cash Flow Ratio 12.64
Sector Free Cash Flow Ratio 30.17
Current Ratio Most Recent Quarter 13.81
Total Cash Per Share 5.67
Book Value Per Share Most Recent Quarter 4.80
Price to Book Ratio 2.49
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 6.67
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.19

Share Statistics

Total Shares Outstanding 130,863,000
Market Capitalization 1,483,986,420
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 9.95%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -76.50%
Annual Earnings Growth -102.18%
Reported EPS 12 Trailing Months -0.05
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.06
Net Income Twelve Trailing Months -6,389,000
Net Income Past Year -6,389,000
Net Income Prior Year 293,156,000
Quarterly Revenue Growth YOY -69.90%
5-Year Revenue Growth 95.66%

Balance Sheet

Total Cash Most Recent Quarter 742,302,000
Total Cash Past Year 742,302,000
Total Cash Prior Year 624,395,000
Net Cash Position Most Recent Quarter 522,406,000
Net Cash Position Past Year 522,406,000
Long Term Debt Past Year 219,896,000
Long Term Debt Prior Year 217,656,000
Total Debt Most Recent Quarter 219,896,000
Equity to Debt Ratio Past Year 0.74
Equity to Debt Ratio Most Recent Quarter 0.74
Total Stockholder Equity Past Year 622,072,000
Total Stockholder Equity Prior Year 581,013,000
Total Stockholder Equity Most Recent Quarter 622,072,000

Options

Put/Call Ratio 0.09
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.25
MACD Signal -0.19
20-Day Bollinger Lower Band 11.28
20-Day Bollinger Middle Band 12.97
20-Day Bollinger Upper Band 14.67
Beta 1.28
RSI 27.87
50-Day SMA 13.24
200-Day SMA 11.24

System

Modified 4/19/2024 10:56:27 PM EST